News & Publications
Press Release
New Study Shows How Genetic Repair Mechanism Helps Seal DNA Breaks
LA JOLLA, CA, October 19, 2006—A new study by researchers
from The Scripps Research Institute, Lawrence Berkeley National
Laboratory, the Washington University School of Medicine, and the
University of Maryland has provided a clearer picture of the final
steps of a critical DNA repair process. When these repair processes
go awry, cells can malfunction, die, or become cancerous.
The study was published in the October 20, 2006 issue of the journal Molecular
Cell.
"These results are exciting because they reveal for the first
time how these proteins can dynamically assemble and change their
shape to join DNA ends during DNA replication and repair," said
a senior author of the paper John Tainer, who is a professor at
Scripps Research, member of Scripps Research's Skaggs Institute
for Chemical Biology, and co-principal investigator of the Structural
Cell Biology of DNA Repair project in Berkeley Lab's Life Sciences
Division.
As the genetic material, DNA is surprisingly reactive and under
continuous assault from environmental toxins and reactive cellular
metabolites, so a means of repairing DNA damage is essential to
maintaining the integrity of our genetic blueprint for future generations.
DNA ligases are enzymes that are an essential part of this process,
repairing millions of DNA breaks generated during the normal course
of a cell's lifetime. Because the reaction joining the ends of
DNA strands to restore the double helix is catalyzed by ligase
enzymes and because this reaction is essential and abundant in
dividing cells, DNA ligases are attractive targets in the development
of new treatments for cancer and other diseases.
Ligase does its job in concert with another ring-shaped protein
known as a sliding clamp. Sliding clamps like the human PCNA
protein are master regulators of DNA repair, providing docking
sites that recruit repair enzymes to the site of damage.
In the recent study, the scientists applied several state-of-the-art
techniques to visualize DNA ligase alone and in complex with PCNA,
using proteins from a model organism called Sulfolobus solfataricus that
has many of the same biochemical characteristics of multicelled
organisms, including humans. To visualize these complex and dynamic
structures at high resolution, the team used a combination of x-ray
crystallography and small angle x-ray scattering (SAXS) at the
SIBYLS beamline at Berkeley Lab's Advanced Light Source.
"This paper shows that the SIBYLS beamline is well suited
to define dynamic interactions that control cell biology and processes
such as cancer," said Tainer. "These reversible complexes
are also critical to efforts in understanding and controlling microbial
responses and pathways."
Prior to the experiment, the scientists expected that DNA ligase
would curl up in complex with the ring-shaped PCNA protein. However,
results showed that ligase remains in an open conformation enabling
other repair proteins to bind PCNA until the DNA is engaged and
ligase snaps shut. The closed conformation of DNA ligase
bound to DNA was imaged in a separate study previously reported
by the same group of investigators.
"Our [new] study shows that DNA ligase switches from an open,
extended shape to a closed, circular shape as it joins together
DNA strands," said Tom Ellenberger, DVM, Ph.D., a senior author
of the paper and the Raymond H. Wittcoff Professor and head of
the Department of Biochemistry and Molecular Biophysics at Washington
University School of Medicine in St. Louis. "The ligase resembles
a wristwatch that cinches around the DNA ends that are being joined
together. When ligase stacks against PCNA and encircles the DNA,
we think this interaction ejects other repair proteins from PCNA.
In this role, ligase may serve as the final arbiter of DNA repair,
certifying that the DNA is in pristine condition and ready for
the final step of DNA end joining."
The challenge for the future will be to study the molecular choreography
of ligase, PCNA, and DNA in the same experiment, which will require
new methods of analyzing SAXS data.
In addition to Tainer and Ellenberger, authors of the study, "A
Flexible Interface between DNA Ligase and PCNA Supports Conformational
Switching and Efficient Ligation of DNA," are John M. Pascal,
Oleg V. Tsodikov, Greg L. Hura, Wei Song, Elizabeth A. Cotner,
Scott Classen, and Alan E. Tomkinson.
Funding from the National Cancer Institute, the National Institute
of General Medical Sciences, and the U.S. Department of Energy
supported this research.
About The Scripps Research Institute and Lawrence Berkeley
National Laboratory
The Scripps Research Institute is one of the world's largest independent,
non-profit biomedical research organizations, at the forefront
of basic biomedical science that seeks to comprehend the most fundamental
processes of life. Scripps Research is internationally recognized
for its discoveries in immunology, molecular and cellular biology,
chemistry, neurosciences, autoimmune, cardiovascular, and infectious
diseases, and synthetic vaccine development. Established in its
current configuration in 1961, it employs approximately 3,000 scientists,
postdoctoral fellows, scientific and other technicians, doctoral
degree graduate students, and administrative and technical support
personnel. Scripps Research is headquartered in La Jolla, California.
It also includes Scripps Florida, whose researchers focus on basic
biomedical science, drug discovery, and technology development.
Currently operating from temporary facilities in Jupiter, Scripps
Florida will move to its permanent campus in 2009.
Both Lawrence Berkeley National Laboratory and Scripps Research
continue the tradition of multidisciplinary scientific teams working
together to solve global problems in human health, technology,
energy, and the environment. Lawrence Berkeley Lab is a U.S. Department
of Energy national laboratory located in Berkeley, California.
It conducts unclassified scientific research and is managed by
the University of California. Its website can be found at http://www.lbl.gov.
For more information contact:
Keith McKeown
10550 North Torrey Pines Road
La Jolla, California 92037
Tel: 858.784.8134
Fax: 858.784.8118
kmckeown@scripps.edu
Copyright © 2006 TSRI.
All rights reserved. Reproduction in whole or in part in any form
or medium with out express written permission of TSRI is prohibited.
|